Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPA3 | P15088 | 2/20 | 0.55 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.44 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | CPA1 | P15085 | 2/20 | 0.40 |
| ▸ | CPB1 | P15086 | 1/20 | 0.40 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1376183 | 0.89 | CPA3 (0.58) | CPA3FOLH1NAALAD2CYP1A2CPA1 | |
| SCHEMBL8566028 | 0.77 | FOLH1 (0.47) | FOLH1NAALAD2 | |
| SCHEMBL1377036 | 0.77 | CPA3 (0.54) | CPA3FOLH1NAALAD2CYP1A2 | |
| SCHEMBL1373606 | 0.77 | CPA3 (0.66) | CPA3FOLH1NAALAD2CYP1A2CPA1 | |
| SCHEMBL5057861 | 0.75 | CPA3 (0.51) | CPA3FOLH1CPB2 | |
| SCHEMBL7350860 | 0.74 | CPA3 (0.71) | CPA3FOLH1CYP1A2CPA1 | |
| SCHEMBL7052257 | 0.73 | CPA3 (0.60) | CPA3FOLH1NAALAD2CYP1A2CPA1 | |
| SCHEMBL3774843 | 0.72 | CPA3 (0.51) | CPA3FOLH1NAALAD2CYP1A2ALDH1A1 | |
| SCHEMBL8427426 | 0.72 | FOLH1 (0.49) | FOLH1NAALAD2CYP1A2 | |
| SCHEMBL3963424 | 0.72 | CPA3 (1.00) | CPA3FOLH1NAALAD2CYP1A2CPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1019369-A1 | THIO DERIVATIVES AS NAALADASE INHIBITORS | GUILFORD PHARMACEUTICALS INC. (US) | 2000-07-19 | — | — | EP | disclosed |
| WO-1998045257-A1 | THIO DERIVATIVES AS NAALADASE INHIBITORS | GUILFORD PHARMACEUTICALS INC. (US) | 1998-10-15 | — | — | WO | disclosed |